Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Recurrence × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 3 Glioblastoma 3 Skin Neoplasms 2 Ovarian Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Hot Flashes 2 Colorectal Neoplasms 2 Vulvodynia 1 Thromboembolism 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Hemorrhage 1 Pleural Effusion, Malignant 1 Platinum Resistant Ovarian Cancer 1 Parathyroid Neoplasms 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma 1 Leukemia, Hairy Cell 1

Interventions

Cyclophosphamide 31 Dexamethasone 28 Cytarabine 20 fludarabine phosphate 18 Rituximab 18 Lenalidomide 16 Methotrexate 15 Bortezomib 15 fludarabine 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 pembrolizumab 12 Peripheral Blood Stem Cell Transplantation 12 Mycophenolic Acid 12 Etoposide 12 Melphalan 11 Gemcitabine 11 Filgrastim 11 Cyclosporine 11 Paclitaxel 10 pomalidomide 9 Carboplatin 9 Vincristine 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Busulfan 8 Brentuximab Vedotin 8 Bevacizumab 8 carfilzomib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00925548 2014-07-24

STRIDE

EMD Serono

Phase 3 Terminated

16 enrolled 6 charts

Breast Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡